Sol-Gel Technologies Ltd. Stock

$8.14

0.36%

Nasdaq, Jul 11, 10:00 pm CET

ISIN

IL0011417206

Symbol

SLGL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Sol-Gel Technologies Ltd. Stock price

$8.14

-71.76 89.81% 5Y

Nasdaq, Closing price Fri, Jul 11 2025

+0.03 0.36%

ISIN

IL0011417206

Symbol

SLGL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

$22.7m

Enterprise Value

$5.8m

Net debt

positive

Cash

$16.9m

Shares outstanding

2.8m

Valuation (TTM | estimate)

P/E

negative | negative

P/S

1.9 | 2.9

EV/Sales

0.5 | 0.7

EV/FCF

P/B

1.1

Financial Health

Equity Ratio

80.5%

Return on Equity

-36.7%

ROCE

-63.9%

ROIC

Debt/Equity

0.0

Financials (TTM | estimate)

Revenue

$12.1m | $7.9m

EBITDA

- | -

EBIT

$-14.4m | $-12.5m

Net Income

$-13.0m | $-1.1m

Free Cash Flow

Growth (TTM | estimate)

Revenue

603.5% | -31.9%

EBITDA

- | -

EBIT

42.4% | -4.5%

Net Income

43.0% | 89.2%

Free Cash Flow

EPS

$-4.7

FCF per Share

Short interest

2.3%

Employees

Rev per Employee

$320.0k

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Get Started for Free Today

Sol-Gel Technologies Ltd. Stock Analysis

Unlock Scores for Free

??

7 Analysts have issued a Sol-Gel Technologies Ltd. forecast:

6x Buy

86%

More details on Analyst Estimates Including Price Targets

7 Analysts have issued a Sol-Gel Technologies Ltd. forecast:

Buy

86%

Hold

14%

Analyst Estimates with Stock Price Targets

Financial data from Sol-Gel Technologies Ltd.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Mar '25		+/- %
Revenue	12 12	603% 603% 100%
- Direct Costs	- -	- -
Gross Profit	- -	- -
- Selling and Administrative Expenses	5.17 5.17	28% 28% 43%
- Research and Development Expense	21 21	9% 9% 176%
EBITDA	- -	- -
- Depreciation and Amortization	- -	- -
EBIT (Operating Income) EBIT	-14 -14	42% 42% -119%
Net Profit	-13 -13	43% 43% -108%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Sol-Gel Technologies Ltd. Stock News

Neutral

GlobeNewsWire

●

about 2 months ago

Sol-Gel Reports First Quarter 2025 Results

NESS ZIONA, Israel, May 23, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March 31, 2025.

Neutral

GlobeNewsWire

●

2 months ago

Sol-Gel Announces Reverse Share Split

NESS ZIONA, Israel, May 01, 2025 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (the “Company”) (NASDAQ: SLGL), a clinical-stage dermatology company, today announced a reverse share split (the “Reverse Split”) of the Company's issued and outstanding ordinary shares, par value NIS 0.1 per share (the “Ordinary Shares”), at the ratio of 10-for-1, such that each ten (10) Ordinary Shares shall be con...

Neutral

GlobeNewsWire

●

3 months ago

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

Sol-Gel to receive $16 million during 2025 Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete its Phase III clinical trial SGT-610 Phase III clinical trial top-line results are expected in the fourth quarter of 2026; a significant milestone in the clinical trial of recruiting more than 80% of the patients has been achieved Sol-G...

More Sol-Gel Technologies Ltd. News

Company Profile

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Head office	Israel
CEO	Moshe Arkin
Employees	36
Founded	1997
Website	www.sol-gel.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now